» Articles » PMID: 35712480

A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Jun 17
PMID 35712480
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Familial lung cancer (FLC) accounts for 8% of lung adenocarcinoma. It is known that a few germline mutations are associated with risk increasing and may provide new screening and treatment option. The goal of this study is to identify an FLC gene among three members of an FLC family.

Methods: To uncover somatic and embryonic mutations linked with familial lung cancer, whole exome sequencing was done on surgical tissues and peripheral blood from three sisters in a family diagnosed with pulmonary lung adenocarcinoma (LUAD). At the same time, single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing data in public databases were enrolled to identify specific gene expression level.

Results: Ataxia Telangiectasia and Rad3-Related Protein (ATR) gene C.7667C >G (p.T2556S) mutation were found in 3 patients with familial lung cancer. Whole-genome sequencing revealed that the three sisters exhibited similar somatic mutation patterns. Besides ATR mutations, common mutated genes (BRCA1, EGFR, and ROS1) that characterize LUAD were also found in 5 tumor samples. Analysis for the ATR expression in LUAD patients by single-cell sequencing data, we found ATR expression of tumor patients at high level in immune cells when compared with normal patients, but the expression of ATR in stromal cells has the opposite result.

Conclusion: We found a germline mutation in the ATR gene in three sisters of a Chinese family affected by familial lung cancer, which may be a genetic factor for lung cancer susceptibility.

Citing Articles

The mathematical exploration for the mechanism of lung adenocarcinoma formation and progression.

Han Y, Chen B, Bi Z, Bian J, Kang R, Shang X Brief Bioinform. 2024; 25(6).

PMID: 39562161 PMC: 11576079. DOI: 10.1093/bib/bbae603.

References
1.
Tibaldi C, Giovannetti E, Vasile E, Boldrini L, Gallegos-Ruiz M, Bernardini I . Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients. J Thorac Oncol. 2011; 6(2):395-6. DOI: 10.1097/JTO.0b013e3182059a6f. View

2.
Przytycki P, Singh M . Differential analysis between somatic mutation and germline variation profiles reveals cancer-related genes. Genome Med. 2017; 9(1):79. PMC: 5574113. DOI: 10.1186/s13073-017-0465-6. View

3.
Tamborero D, Gonzalez-Perez A, Perez-Llamas C, Deu-Pons J, Kandoth C, Reimand J . Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci Rep. 2013; 3:2650. PMC: 3788361. DOI: 10.1038/srep02650. View

4.
Bailey-Wilson J, Amos C, Pinney S, Petersen G, de Andrade M, Wiest J . A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet. 2004; 75(3):460-74. PMC: 1182024. DOI: 10.1086/423857. View

5.
Renieri A, Mencarelli M, Cetta F, Baldassarri M, Mari F, Furini S . Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients. Lung Cancer. 2014; 85(2):168-74. DOI: 10.1016/j.lungcan.2014.05.020. View